An interventional study of Calcivis System in Dental Caries, sponsored by Calcivis Ltd. Completed at 1 site in United Kingdom. Open to participants aged 12 Years to 100 Years. Per ClinicalTrials.gov, last updated 2019-02-28.
Sponsored by Calcivis Ltd · Not applicable, Interventional, and Other
This is a prospective, single-centre clinical study to monitor caries lesion activity in orthodontic patients with the Calcivis System over a 12 week period. Dentists will identify patients who have had dental appliances in place for a minimum of 12 months and have visible white spot lesions on the anterior surfaces of incisors and / or canines at de-bond. Following de-bond, images of the tooth surface will be taken with the Calcivis System. Presence or absence of elevated luminescence on the images will indicate activity / inactivity. Only patients with at least one tooth identified as active with the Calcivis System will continue in the study and be followed up at 2, 4, 8 and 12 weeks de-bond. Images of the active teeth will be taken with the Calcivis System as before, at each follow-up visit.
The percentage of teeth showing luminescence using the Calcivis System will be calculated and summarised for all subjects for each post-baseline visit, and additionally by Investigator. This will then be summarised over all subjects for each post-baseline visit.
Dental caries (tooth decay) is a significant clinical and public health problem. The development of caries lesions involves a net mineral loss of dental tissue, which can lead to progressive loss of tooth structure and associated pain and disease. Detecting, assessing, diagnosis and treating such lesions are core activities in dentistry. Currently the main detection and diagnosis aids are visual inspection and the used of a probe, together with X-ray images. Determination of the activity status of a lesion (how likely it is to progress) is requires to assess treatment needs. Currently methods are problematic and involve the clinicians' subjective assessment and / or monitoring of lesions progression over a number of visits.
It is generally recognised and reported in the dental literature that patients undergoing orthodontic treatment with fixed appliances find it difficult to maintain meticulous oral hygiene and that, as a result, plaque accumulates adjacent to the orthodontic brackets (which are usually placed on the buccal, Free Smooth, surfaces of teeth, which are readily visible) holding the metal wires which are involved in moving the teeth - thus white spot lesions commonly develop at these sites of plaque stagnation. These lesions are, de facto, actively developing during orthodontic treatment, thus represent 'active lesions'. Once the wires and brackets are removed post-treatment, normal oral hygiene can be resumed, the plaque/biofilm over these lesions is readily removed and they become arrested, i.e. the demineralisation process ceases. Thus during a short period of time - a matter of weeks - there is usually a transition from active to inactive status for these 'orthodontically-induced' white spot lesions. By assessing and monitoring these lesions, using the Calcivis device, at relatively short intervals during this period of lesion status transition immediately post orthodontic treatment it would be possible to monitor the reduction in the demineralisation process as these lesions arrest.
A previous clinical study on the prototype of the Calcivis System has been conducted. The results concluded that the Calcivis System was safe for use and the level of agreement between elevated luminescence and areas of expected activity was above 70% and not due to chance (NCT02098304).
This prospective, single-centre clinical study has been designed to assess the use of the Calcivis System for monitoring the activity levels of post-orthodontic treatment white spot lesions over time. The Dentist will share the images with the patient
The device under evaluation comprises a hand-held customized intra-oral camera which takes both black \& white and luminescent images of a lesion on a tooth surface while simultaneously applying a photoprotein solution. The photo-protein detects free calcium ions on the tooth surface and produces a light signal if the caries lesion is active.
For the study, patients attending routine Orthodontic appointments to have their appliances checked, and who are identified by the Investigator as meeting the Inclusion and Exclusion criteria, and are ready for de-bond, will be approached to discuss their possible participation in the study.
Patients will be given a Patient Information Sheet to read and time to consider their participation in the study. If they are happy to participate they will asked to attend for five Study Visits - de-bond (baseline), 2, 4, 8 and 12 weeks. Written informed consent will be taken before any study procedures are conducted. As children under the age of 16 are included in this study, parent / guardian consent will be taken where appropriate.
At study Visit 1, demographics, relevant medications, oral hygiene and orthodontic history data will be collected.
The orthodontist will carry out an oral examination and the tooth / teeth identified as per inclusion / exclusion criteria, will be cleaned with prophy paste, rinsed with tap water and a 3-in-1 air / water spray before being air dried and staged as per ICDAS coding. Reference intra-oral photographs will be taken of each tooth. The free smooth tooth surfaces will again be air dried before taking the black \& white and luminescent images with the Calcivis System. After imaging is completed, patients rinse out with tap water. Adverse event will be collected throughout. The dentist will then share the images of the teeth with the patient. Post imaging questionnaires will be completed by each patient at the end of Study Visit 1 and user questionnaires completed by the dental team at the end of each Study Visit 1 day.
Only patients who have 'active' lesions on de-bond, as confirmed with the Calcivis System at the baseline visit, will be followed up in this study. If all lesions are assessed as 'inactive', the patient will be withdrawn from the study
Eligible patients will return for Study Visits at 2, 4, 8 and 12 weeks post-de-bond. At each of these visits, following a reference photograph of the teeth, each tooth which was "active" at Study Visit 1 will again be imaged with the Calcivis System as described above and the images shared with the patient. In addition, both Patient and User Questionnaires will be completed at the final Study Visit at 12 weeks.
1,109 studies on the registry are indexed under Dental Caries; 197 are open to participants now.
This study's enrollment of 36 is below the median of 60 across 916 interventional studies indexed under Dental Caries.
Browse Dental Caries studies →Calcivis Ltd is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Imaging with the Calcivis System
Device: Calcivis System
Following de-bond, and identification of active post-orthodontic white spot lesions at baseline with the Calcivis System, each active tooth will be again be imaged at 2, 4, 8 and 12 weeks. Both black \& white and luminescent images images of the teeth are taken. The images of each tooth are overlaid and a resulting demineralization map of the tooth produced, indicating areas of elevated bioluminescence corresponding to free calcium ions on the surface of the tooth (active caries)
Also known as: Calcivis Caries Activity Imaging System
Presence or Absence of Elevated Luminescence
Percentage of active teeth showing luminescence (as measured by Calcivis System imaging) over time
Time frame: 0, 2, 4, 8 and 12 weeks
Presence or Absence of Elevated Luminescence
Percentage of active teeth showing luminescence (as measured by Calcivis System imaging) over time, per Investigator
Time frame: 0, 2, 4, 8 and 12 weeks post de-bond
Number of Non-patient Related Adverse Events With the Calcivis System
All adverse events and device deficiencies were collected throughout the study on Adverse Event Forms
Time frame: 0 days, 2, 4, 8 and 12 weeks
Patient Experience
Completion of Patient Questionnaires after imaging with the Calcivis System
Time frame: Baseline
Patient Experience
Completion of Patient Questionnaires after imaging with the Calcivis System at patient's final visit
Time frame: Final Visit - either 8 or 12 weeks post debond
User Questionnaires
Completion of User Questionnaires after imaging with the Calcivis System
Time frame: Baseline visit
Patients were recruited by two Investigators from a routine NHS Orthodontic clinic between 15 February 2017 and 01 May 2018. Of the 36 patients attending Visit 1, 30 were eligible for Calcivis imaging ( 3 patients were pregnant, 2 patients had appliances on less than 12 months and I patient did not have visible white spot lesions).
| Milestone | Active Post-othodontic Lesions |
|---|---|
| Started | 30 |
| Completed | 22 |
| Not completed | 8 |
| Withdrew: Lost to follow-up | 3 |
| Withdrew: Withdrawal by subject | 2 |
| Withdrew: No white spot lesions | 3 |
Percentage of active teeth showing luminescence (as measured by Calcivis System imaging) over time
| % active teeth with luminescence | Active Post-othodontic Lesions |
|---|---|
| Baseline | 61.7 |
| 2 weeks post de-bond | 17.3 |
| 4 weeks post de-bond | 6.0 |
| 8 weeks post de-bond | 10.2 |
| 12 weeks post de-bond | 6.3 |
Percentage of active teeth showing luminescence (as measured by Calcivis System imaging) over time, per Investigator
| % active teeth with luminescence | Post-orthodontic Lesions |
|---|---|
| Site 11 - Baseline | 58.9 |
| Site 11 - 2 weeks post de-bond | 11.4 |
| Site 11 - 4 weeks post de-bond | 2.6 |
| Site 11 - 8 weeks post de-bond | 6.3 |
| Site 11 - 12 weeks posar de-bond | 8.3 |
| Site 31 - Baseline | 100.0 |
| Site 31 - 2 weeks post debond | 50.0 |
| Site 31 - 4 weeks posat de-bond | 37.5 |
| Site 31 - 8 weeks post de-bond | 50.0 |
| Site 31 - 12 weeks post de-bond | 0.0 |
All adverse events and device deficiencies were collected throughout the study on Adverse Event Forms
| Non-patient-related Adverse Events | Active Post-othodontic Lesions |
|---|---|
| Number of Non-patient Related Adverse Events With the Calcivis System | 3 |
Completion of Patient Questionnaires after imaging with the Calcivis System
| participants | Post-orthodontic Lesions |
|---|---|
| Calcivis System experience:good | 27 |
| Calcivis System experience:neither good nor bad | 3 |
| Calcivis System experience:bad | 0 |
| Calcivis System - seeing images:helpful | 30 |
| CalcivisSystem-images-neither good nor bad | 0 |
| CalcivisSystem - seeing images - bad | 0 |
Completion of Patient Questionnaires after imaging with the Calcivis System at patient's final visit
| Participants | Post-orthodontic Lesions |
|---|---|
| Calcivis System experienc: good | 16 |
| Calcivis System experience: neither good nor bad | 2 |
| Calcivis System experience: bad | 0 |
| Calcivis System-seeing images: helpful | 18 |
| CalcivisSystem images:neitherhelpfuln | 0 |
| Calcivis System - seeing images: unhelpful | 0 |
Completion of User Questionnaires after imaging with the Calcivis System
| User Questionniares | Active Post-othodontic Lesions |
|---|---|
| Calcivis System preparation:easy | 21 |
| CalcivisSystempreparation:neithereasynordifficult | 9 |
| Calcivis system preparation: difficult | 0 |
| Calcivis System use: easy | 17 |
| Calcivis System use: neither easy nor difficult | 11 |
| calcivis System use: difficult | 2 |
| Calcivis System experience: good | 24 |
| Calcivis System experience:neither good nor bad | 4 |
| Calcivis System experience: bad | 2 |
| Understand instructions:easy | 19 |
| Understand instructions:neither easy nor difficult | 11 |
| Understand instructions: difficult | 0 |
Collected over 12 weeks post baseline visit. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Active Post-othodontic Lesions | 0/30 (0%) | 0/30 (0%) | 3/30 (10%) |
| Event | Active Post-othodontic Lesions |
|---|---|
| non patient related adverse eventsProduct Issues | 3/30 |
Of the 30 patients, 119 teeth were imaged
| Age, Continuous(years) | Active Post-othodontic Lesions |
|---|---|
| Mean | 19.9 ± 6.52 |
| Sex: Female, Male(Participants) | Active Post-othodontic Lesions |
|---|---|
| Female | 16 |
| Male | 14 |
| Race and Ethnicity Not Collected(Participants) | Active Post-othodontic Lesions |
|---|
| Region of Enrollment(participants) | Active Post-othodontic Lesions |
|---|---|
| United Kingdom | 30 |
| Number of teeth imaged and deemed active(Teeth) | Active Post-othodontic Lesions |
|---|---|
| Number | 73 |
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.